Stifel Upgrades Editas Medicine (EDIT) to Buy, 'Difficult To Justify Current Valuation'
Go back to Stifel Upgrades Editas Medicine (EDIT) to Buy, 'Difficult To Justify Current Valuation'| (NASDAQ: EDIT) | Delayed: 2.93 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.93 | 52 Week High | $43.99 | |||
| Open | $2.93 | 52 Week Low | $12.43 | |||
| Day High | $2.93 | P/E | N/A | |||
| Day Low | $2.93 | EPS | $0.00 | |||
| Volume | 3,062 | |||||



